Standard Biotools
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3,222 | $19,552 | $21,762 | $40,795 |
Gross Profit | 2,690 | 9,484 | 10,628 | 19,741 |
EBITDA | -19,331 | -31,293 | -14,279 | -22,011 |
EBIT | -32,890 | -18,273 | -26,182 | |
Net Income | -57,963 | -34,687 | -33,459 | -26,033 |
Net Change In Cash | 3,222 | 19,552 | 21,762 | 40,795 |
Free Cash Flow | -1,673 | -23,088 | -22,555 | -35,337 |
Cash | 118,213 | 129,418 | 158,617 | 150,880 |
Basic Shares | 385,048 | 382,630 | 380,498 | 378,228 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $85,331 | $174,432 | $106,340 | $97,948 |
Gross Profit | 42,543 | 84,262 | 50,450 | 37,051 |
EBITDA | -94,961 | -118,135 | -54,457 | -173,570 |
EBIT | -96,676 | -134,996 | -69,637 | -188,597 |
Net Income | -74,896 | -138,885 | -74,656 | -190,098 |
Net Change In Cash | 85,331 | 174,432 | 106,340 | 97,948 |
Cost of Revenue | 53,261 | |||
Free Cash Flow | -82,653 | -151,809 | -46,118 | -93,195 |
Cash | 118,213 | 166,728 | 51,704 | 81,309 |
Basic Shares | 381,623 | 352,670 | 79,160 | 78,305 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.06 |
2025-09-30 | -$0.09 |
2025-06-30 | -$0.02 |
